-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, AVlgsWaCDNWp0LlW8H1i/ckJK31nN5Si0OXJyPOM716ioT925BGrYPejH02ZDVtF cjruOdVHAdH1IqCcLLwJOQ== 0000019617-94-000107.txt : 19941202 0000019617-94-000107.hdr.sgml : 19941202 ACCESSION NUMBER: 0000019617-94-000107 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19941201 ITEM INFORMATION: Other events FILED AS OF DATE: 19941201 SROS: NYSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: CHEMICAL BANKING CORP CENTRAL INDEX KEY: 0000019617 STANDARD INDUSTRIAL CLASSIFICATION: STATE COMMERCIAL BANKS [6022] IRS NUMBER: 132624428 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-05805 FILM NUMBER: 94562995 BUSINESS ADDRESS: STREET 1: 270 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 2122706000 FORMER COMPANY: FORMER CONFORMED NAME: CHEMICAL NEW YORK CORP DATE OF NAME CHANGE: 19880508 8-K 1 FORM 8-K DATED 12/01/94 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of the Report: December 1, 1994 ---------------- Commission file number 1-5805 ------ CHEMICAL BANKING CORPORATION ---------------------------------------------------- (Exact name of registrant as specified in its charter) Delaware 13-2624428 - ---------------------- ------------------ (State or other jurisdiction (I.R.S. Employer of incorporation) Identification No.) 270 Park Avenue, New York, NY 10017 - ------------------------------ ------------ (Address of principal executive Offices) (Zip Code) Registrant's telephone number, including area code (212) 270-6000 -------------- 2 Item 5. Other Events - --------------------- Chemical Banking Corporation (the "Corporation") announced on December 1, 1994 a two-year program designed to produce earnings per share growth of more than 15 percent in 1995 and 1996, and a core efficiency ratio of 57 percent and a return on common shareholders' equity of 16 percent in 1996. Under the program, the Corporation will reduce its existing cost base by $440 million ($230 million in 1995) from a number of actions, including the elimination of 3,700 positions, and at the same time focus $180 million of new investment spending in a number of its high growth businesses. The net result, the Corporation announced, should be flat expenses in 1995 and 1996 and annual revenue growth targeted at 4 to 6 percent. To cover the costs associated with severance and the disposition of certain facilities, the Corporation announced it will take a pre-tax restructuring charge of $260 million in the 1994 fourth quarter. The Corporation also announced its intention to sell approximately 60 percent of Chemical Bank New Jersey and to integrate the remaining branches in the northeast quadrant of New Jersey into its consumer and middle market franchise serving Metropolitan New York. The Corporation also announced that it is exploring options to sell or substantially reduce its 40 percent investment in The CIT Group. In addition, the Corporation announced it plans to repurchase up to 6 million shares of its common stock over the next 12 months. This follows a 10 million share buyback program completed in September. The Corporation announced that it would consider expanding the new stock buyback program upon completion of the contemplated divestitures. The Corporation also announced that it will be designating approximately $950 million of real estate loans and foreclosed property as "held for sale." The Corporation announced that most of these assets are nonperforming and that it would take a charge against the reserve for loan losses of approximately $150 million in the 1994 fourth quarter to facilitate rapid disposition. The Corporation's Press Release announcing this program is incorporated herein and attached hereto. Item 7. Financial Statements, Pro Forma Financial Information and Exhibits - ------------------------------------------------------------------ The following exhibits are filed with this Report: Exhibit Number Description -------------- ----------- 99 Press Release - Program to improve earnings per share and return on equity. 3 SIGNATURE Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHEMICAL BANKING CORPORATION (Registrant) Dated December 1, 1994 by /s/Joseph L. Sclafani ---------------- ------------------------- Joseph L. Sclafani Controller [Principal Accounting Officer] 4 EXHIBIT INDEX Exhibit Number Description Page at Which Located - -------------- ----------- --------------------- 99 Press Release 5 EX-99 2 PRESS RELEASE 5 CHEMICAL BANKING CORPORATION ANNOUNCES PROGRAM TO IMPROVE EARNINGS PER SHARE AND RETURN ON EQUITY New York, December 1, 1994 -- Chemical Banking Corporation today announced a two-year program designed to produce earnings per share growth of more than 15 percent in 1995 and 1996, and a core efficiency ratio of 57 percent and a return on common shareholders' equity of 16 percent in 1996. Under the program, Chemical will reduce its existing cost base by $440 million ($230 million in 1995) from a number of actions, including the elimination of 3,700 positions, and at the same time focus $180 million of new investment spending in a number of its high growth businesses. The net result, the company said, should be flat expenses in 1995 and 1996 and annual revenue growth targeted at 4 to 6 percent. To cover the costs associated with severance and the disposition of certain facilities, Chemical said it will take a pre-tax restructuring charge of $260 million in the current quarter. The company also announced its intention to sell approximately 60 percent of Chemical Bank New Jersey and to integrate the remaining branches in the northeast quadrant of New Jersey into its consumer and middle market franchise serving Metropolitan New York. Chemical also announced that it is exploring options to sell or substantially reduce its 40 percent investment in The CIT Group. In addition, Chemical said it plans to repurchase up to 6 million shares of its common stock over the next 12 months. This follows a 10 million share buyback program completed in September. Chemical said that it would consider expanding the new stock buyback program upon completion of the contemplated divestitures. Chemical also announced that it will be designating approximately $950 million of real estate loans and foreclosed property as "held for sale." The company said that most of these assets are nonperforming and that it would take a charge against the reserve for loan losses of approximately $150 million in the current quarter to facilitate rapid disposition. - ------------------------------------------------------------------- Press Contacts: John Stefans Investor Contact: John Borden 212-270-7438 212-270-7318 Ken Herz 212-270-4621 - ------------------------------------------------------------------- -----END PRIVACY-ENHANCED MESSAGE-----